Eskander, E. F., Abd-Rabou, A. A., Mohamed, M. S., Yahya, S. M. M., & Shaker, O. G. (2012). Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy? Springer-Verlag.
シカゴスタイル引用形Eskander, Emad F., Ahmed A. Abd-Rabou, Mervat S. Mohamed, Shaymaa M. M. Yahya, , Olfat G. Shaker. Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy? Springer-Verlag, 2012.
MLA引用形式Eskander, Emad F., et al. Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy? Springer-Verlag, 2012.
警告: この引用は必ずしも正確ではありません.